2025-04-05 - Analysis Report
## Starbucks Corp (SBUX) Stock Review

**0. Executive Summary:**

Starbucks Corp is a global coffeehouse chain.  This report analyzes SBUX's recent performance against the S&P 500 (VOO), considering its price movements, financial indicators, and earnings.  SBUX shows significantly underperformance compared to the S&P 500, exhibiting negative alpha and high beta values, indicating high risk and volatility.  Further investigation is needed to determine future investment potential.


**1. Performance Comparison:**

* **SBUX Cumulative Return:** 7.795%
* **VOO (S&P 500) Cumulative Return:** 71.018%
* **Return Difference:** -63.2%
* **Relative Divergence:** 35.1% (This means SBUX's underperformance relative to VOO is at the 35.1st percentile of its historical range of under/outperformance.)

SBUX significantly underperformed the S&P 500 over the period reviewed.  The negative return difference highlights substantial lag.

**Alpha and Beta Analysis:**

The provided data shows consistently negative or low CAGR for SBUX across the periods.  The high and increasing Beta values (0.0 to 3.0) indicate high sensitivity to market movements, implying increased risk compared to the overall market. The negative Alpha consistently shows SBUX underperformed its benchmark during this period.  The high Maximum Drawdown (MDD) values further reinforces the volatility and risk associated with SBUX.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 1.0% | 58.2% | -29.0% | 0.0 | 55.9 |
| 2016-2018  | 1.0% | 59.2% | -16.0% | 0.3 | 64.2 |
| 2017-2019  | 49.0% | 59.2% | 20.0% | 0.8 | 89.3 |
| 2018-2020  | 65.0% | 59.2% | 36.0% | 1.8 | 110.9 |
| 2019-2021  | 55.0% | 25.6% | -20.0% | 2.1 | 123.2 |
| 2020-2022  | -25.0% | 60.8% | -46.0% | 2.4 | 107.0 |
| 2021-2023  | -36.0% | 65.0% | -65.0% | 2.8 | 105.7 |
| 2022-2024  | -38.0% | 67.5% | -53.0% | 3.0 | 103.1 |
| 2023-2025  | -19.0% | 67.5% | -22.0% | 2.5 | 93.3 |


**2. Recent Price Movement:**

* **Closing Price:** $82.10
* **Previous Close:** $88.26
* **5-Day Moving Average:** $93.22
* **20-Day Moving Average:** $96.93
* **60-Day Moving Average:** $103.10

The closing price is significantly below all three moving averages, suggesting a downtrend.  The recent price change of -$6.98 indicates a sharp decline.


**3. Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4693 (High Risk)
* **RSI:** 20.31 (Oversold)
* **PPO:** -1.13 (Negative momentum)
* **20-Day Relative Divergence Change:** -2.1 (Short-term downtrend)
* **Expected Return:** -96.5% (This extremely negative expected return needs further clarification as to what this metric specifically refers to, and how it was calculated.  It does not seem to align with the other data presented.)

The technical indicators paint a bearish picture. The over-sold RSI coupled with negative PPO and relative divergence suggest a possible short-term reversal.  However, the MRI's high risk score points to continued uncertainty. The exceptionally low expected return raises serious concerns about future performance.  The large price drop of -$6.98 further reinforces the negative trend, indicating a significant event or shift in market sentiment.


**4. Recent Earnings Analysis:**

| Date       | EPS    | Revenue     |
|------------|--------|-------------|
| 2025-01-28 | $0.69  | $9.40 B     |
| 2024-07-30 | $0.93  | $9.11 B     |
| 2024-04-30 | $0.68  | $8.56 B     |
| 2024-01-30 | $0.90  | $9.43 B     |
| 2025-01-28 | $0.90  | $9.43 B     | *(Note: Duplicate entry)*


There's a fluctuation in EPS and revenue.  Further analysis is needed to determine if these fluctuations are due to seasonal factors, market conditions, or other underlying causes. Note the duplicate entry for 2025-01-28. Data cleaning and confirmation are necessary before drawing conclusions.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue    | Profit Margin |
|---------|------------|---------------|
| 2024-12-31 | $9.40B     | 24.49%        |
| 2024-09-30 | $9.07B     | 26.25%        |
| 2024-06-30 | $9.11B     | 27.91%        |
| 2024-03-31 | $8.56B     | 25.58%        |
| 2023-12-31 | $9.43B     | 27.51%        |

Revenue remains relatively stable, but profit margins fluctuate.

**Capital and Profitability:**

| Quarter | Equity    | ROE         |
|---------|------------|-------------|
| 2024-12-31 | -$7.47B    | -10.45%      |
| 2024-09-30 | -$7.45B    | -12.21%      |
| 2024-06-30 | -$7.95B    | -13.28%      |
| 2024-03-31 | -$8.45B    | -9.14%       |
| 2023-12-31 | -$8.62B    | -11.89%      |

Negative equity and ROE across all quarters indicate significant financial challenges for SBUX. This is a serious concern and requires further investigation into the cause of these negative values.

**6. Overall Analysis:**

SBUX shows significant underperformance compared to the S&P 500, exhibiting negative alpha, high beta, and a consistently negative expected return.  The company faces financial challenges indicated by negative equity and ROE.  While revenue is relatively stable, profit margins fluctuate.  Technical indicators suggest an oversold condition but also highlight high risk.  The sharp recent price drop underscores significant market concerns.  Before considering any investment, a thorough review of the underlying causes of the negative financial indicators and the exceptionally low expected return is crucial. The data provided requires further validation and clarification to provide a more conclusive assessment.
